The antispastic effects of Ba 34647 (B-4-p-chlorophenyl-gamma-amino-butyric acid) a GABA derivative. 1974

Y D Lapierre, and R Elie, and L Tetreault

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D009135 Muscular Diseases Acquired, familial, and congenital disorders of SKELETAL MUSCLE and SMOOTH MUSCLE. Muscle Disorders,Myopathies,Myopathic Conditions,Muscle Disorder,Muscular Disease,Myopathic Condition,Myopathy
D010329 Patella The flat, triangular bone situated at the anterior part of the KNEE. Knee Cap,Kneecap,Knee Caps,Kneecaps,Patellas
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D012026 Reflex, Stretch Reflex contraction of a muscle in response to stretching, which stimulates muscle proprioceptors. Reflex, Tendon,Stretch Reflex,Tendon Reflex
D002722 Chlorobenzenes Aromatic organic compounds with the chemical formula C6H5Cln.
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004576 Electromyography Recording of the changes in electric potential of muscle by means of surface or needle electrodes. Electromyogram,Surface Electromyography,Electromyograms,Electromyographies,Electromyographies, Surface,Electromyography, Surface,Surface Electromyographies
D005680 gamma-Aminobutyric Acid The most common inhibitory neurotransmitter in the central nervous system. 4-Aminobutyric Acid,GABA,4-Aminobutanoic Acid,Aminalon,Aminalone,Gammalon,Lithium GABA,gamma-Aminobutyric Acid, Calcium Salt (2:1),gamma-Aminobutyric Acid, Hydrochloride,gamma-Aminobutyric Acid, Monolithium Salt,gamma-Aminobutyric Acid, Monosodium Salt,gamma-Aminobutyric Acid, Zinc Salt (2:1),4 Aminobutanoic Acid,4 Aminobutyric Acid,Acid, Hydrochloride gamma-Aminobutyric,GABA, Lithium,Hydrochloride gamma-Aminobutyric Acid,gamma Aminobutyric Acid,gamma Aminobutyric Acid, Hydrochloride,gamma Aminobutyric Acid, Monolithium Salt,gamma Aminobutyric Acid, Monosodium Salt

Related Publications

Y D Lapierre, and R Elie, and L Tetreault
January 1971, Rivista di neurologia,
Y D Lapierre, and R Elie, and L Tetreault
January 1970, Acta neurologica Scandinavica,
Y D Lapierre, and R Elie, and L Tetreault
July 1985, The Analyst,
Y D Lapierre, and R Elie, and L Tetreault
October 1974, American journal of physical medicine,
Y D Lapierre, and R Elie, and L Tetreault
November 1974, Neuropharmacology,
Y D Lapierre, and R Elie, and L Tetreault
January 1971, Rivista di neurologia,
Y D Lapierre, and R Elie, and L Tetreault
March 2003, Journal of neural transmission (Vienna, Austria : 1996),
Y D Lapierre, and R Elie, and L Tetreault
January 1986, Advances in biochemical psychopharmacology,
Copied contents to your clipboard!